LORA-PITA IV General Investigation

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Status Epilepticus
Interventions
DRUG

Lorazepam

"The usual dose of lorazepam in adults is 4 mg administered intravenously. The drug should be given slowly with the administration rate at 2 mg/min as a guide. If necessary, 4 mg may be added but the dose should not exceed 8 mg as the sum of initial and additional doses.~The usual dose of lorazepam in children aged 3 months or older is 0.05 mg/kg (up to 4 mg) administered intravenously. The drug should be given slowly with the administration rate at 2 mg/min as a guide. If necessary, 0.05 mg/kg may be added but the dose should not exceed 0.1 mg/kg as the sum of initial and additional doses."

Trial Locations (1)

Unknown

Pfizer Local Country office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03905798 - LORA-PITA IV General Investigation | Biotech Hunter | Biotech Hunter